74 results
Page 2 of 4
8-K
EX-10.26
eb4m3 4ijcaomdn
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-3.2
hgi1jeehmf9ooi7 0ap
5 Oct 23
Index to Financial Statements
5:12pm
424B3
8lv306p16or6r5mb4
21 Sep 23
Prospectus supplement
7:31pm
424B3
2rcpb8q 620
14 Aug 23
Prospectus supplement
4:30pm
425
EX-99.1
av8lqho obxyigp8bi
26 Jul 23
Business combination disclosure
11:55am
425
rkd1w57sfr50dyrmjex
26 Jul 23
Business combination disclosure
11:55am
8-K
EX-99.1
mehvugx9 milb3dbbf6l
26 Jul 23
For Investor Use Only For Investor Use Only Maximizing Immune Integrity Investor Event Presentation July 2023
11:54am
8-K
w8s6p otgjmw4
26 Jul 23
For Investor Use Only For Investor Use Only Maximizing Immune Integrity Investor Event Presentation July 2023
11:54am
425
ijo1unbmvyvrhsa
17 Jul 23
Business combination disclosure
8:00am
425
EX-99.2
z0ijp2gyn9etc6 rmocs
17 Jul 23
Business combination disclosure
8:00am
425
EX-99.3
90hc5w95rbpqodm8
17 Jul 23
Business combination disclosure
8:00am
8-K
exxxzks0
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
8-K
EX-99.3
yygofml3iqx 8brq2
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
8-K
EX-99.2
trvwviwj 033rb6w
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am